@kayysbvby's Wegovy weight loss claims, fact-checked

TikToker @kayysbvby posted about expecting to be "SKINNY" with Wegovy, semaglutide, and tirzepatide. Her 30,000-view video reflects the growing social media buzz around GLP-1 medications.

But her casual mention of multiple drugs suggests some confusion about what she's actually taking. Let's separate the hype from the science.

What does this video actually claim?

The creator implies she'll achieve significant weight loss using Wegovy, semaglutide, and tirzepatide. She doesn't specify which drug she's taking or provide dosage details.

Her hashtags suggest she's treating these as interchangeable weight loss solutions. The video's tone presents dramatic weight loss as inevitable rather than discussing realistic expectations or timelines.

This reflects a common pattern in GLP-1 social media content where creators focus on desired outcomes rather than the actual treatment process or potential challenges.

Does the science support dramatic weight loss claims?

Yes, but with important caveats about timeline and individual variation. The STEP 1 trial (Wilding et al., NEJM, 2021) found 14.9% average body weight loss with 2.4mg semaglutide over 68 weeks.

For tirzepatide, the SURMOUNT-1 trial (Jastreboff et al., NEJM, 2022) showed even higher results. Participants lost 20.9% of body weight on average with the 15mg dose over 72 weeks.

However, these are averages from clinical trials with strict protocols. Real-world results vary significantly, and the process takes over a year to achieve maximum effects.

What did she get wrong about these medications?

Her biggest error is lumping semaglutide and tirzepatide together as if they're the same drug. Semaglutide targets GLP-1 receptors only, while tirzepatide hits both GLP-1 and GIP receptors.

She also doesn't mention that Wegovy IS semaglutide, just at a higher dose (2.4mg) than Ozempic (up to 2mg). Using both hashtags suggests she doesn't understand they're the same active ingredient.

The timeline matters too. These medications require 4-5 months of dose escalation before reaching maintenance levels, and peak effects aren't seen until 12-18 months of consistent use.

What should you know about realistic expectations?

GLP-1 medications work, but they're not magic bullets. About 86% of people in the STEP 1 trial lost at least 5% of their body weight, but only 50% achieved 15% or more weight loss.

Side effects are common during the initial months. Nausea affects 44% of semaglutide users, and 24% experience vomiting according to FDA prescribing information.

The medications also require lifestyle changes to maximize effectiveness. Clinical trials included counseling on diet and exercise, not just the injections alone. Without insurance coverage, monthly costs range from $900-$1,200, making long-term adherence challenging for many patients.